What is TB-500, and how is it different from BPC-157?
They are not the same thing, and TB-500 is not thymosin beta-4
This is the first place the internet gets it wrong. TB-500 is frequently sold as "thymosin beta-4," and they are not identical. Thymosin beta-4 is a naturally occurring 43-amino-acid protein. TB-500 is a short synthetic fragment of it. A fragment of a molecule is not the molecule, and evidence about one does not automatically transfer to the other.
The FDA treats them as separate entries, which tells you the agency doesn't consider them interchangeable either. If a seller uses the two names as synonyms, that tells you something about the seller.
What the evidence base actually looks like
Thin. That is the honest summary.
Most of what circulates about both compounds comes from animal work — rats, mostly — and from cell studies. Those are legitimate places for science to start. They are not places for it to finish. The step that matters, randomized controlled trials in humans measuring whether an injury heals faster, has not been completed for either compound.
This gets misrepresented constantly. "Studies show" is technically true and practically misleading when the studies are rodent tendon models. A result in a rat is a hypothesis in a human.
Where they stand with the FDA
Both BPC-157 and TB-500 are on the FDA's Category 2 list of bulk drug substances — substances the agency has identified significant safety concerns about, which bars compounding pharmacies from making them. In July 2026 an FDA advisory committee took up BPC-157 along with several other peptides including TB-500, Semax, KPV, MOTS-c and epitalon. An advisory vote is a recommendation, not an approval, and neither compound is an approved drug today.
What that means practically: anything sold outside that framework isn't a prescription product. It's an unapproved drug, and the labels you see on the websites selling it — "for research use only," "not for human consumption" — are there for the seller's protection, not yours.
If you compete in a tested sport, this is disqualifying
BPC-157 is prohibited under WADA's S0 category — non-approved substances — and has been explicitly named since around 2022. TB-500 is prohibited under S2.3, growth factors. Both are banned at all times, not just in competition, which means an out-of-competition test can end your season regardless of when you took it.
If you compete in anything governed by WADA or USADA rules, this category is simply off the table. There is no version of this that is worth a four-year sanction.
What we actually know moves soft-tissue recovery
This is the part nobody clicks on, and it's the part with the evidence behind it.
| Lever | What it does |
|---|---|
| Progressive loading | Tendon and connective tissue remodel in response to graded mechanical load. This is the most evidence-backed intervention in tendinopathy rehab, and it is the one that requires a coach who knows how to scale it. |
| Sleep | Growth hormone release is largely tied to slow-wave sleep. Chronic short sleep measurably impairs tissue repair — and it is free. |
| Protein intake | Adequate daily protein supports the repair process. Most people under-eat it, especially while dieting. |
| Time under management | Most soft-tissue injuries resolve with sensible load management. The peptide conversation often replaces the boring thing that works. |
None of that is exciting. All of it is established. If someone is injured and asking about peptides before they've fixed sleep, protein and how they're loading the tissue, the peptide is not the missing piece.
What we tell members at Boom
Our coaches educate. They do not dose, they do not recommend compounds, and they do not diagnose. If you're dealing with something that isn't resolving, the answer is a licensed provider who can examine you, order imaging or labs, and tell you what's actually wrong — plus a coach who can adjust your training around it so you keep making progress in the meantime.
Read this first. This article is education, not medical advice, and not a recommendation to take anything. Every compound named here requires a licensed medical provider who has reviewed your history and can order labs. Nothing here is a protocol, and no doses appear anywhere in it on purpose. Regulatory and anti-doping status is current as of September 2026 and changes.
Frequently asked
Is TB-500 the same as thymosin beta-4?
No. Thymosin beta-4 is a full 43-amino-acid protein; TB-500 is a synthetic fragment of it. They are listed separately by the FDA and evidence about one does not transfer to the other.
Is BPC-157 legal in 2026?
It is not an FDA-approved drug. It sits on the FDA's Category 2 bulk substances list, which bars compounding pharmacies from making it. A July 2026 advisory committee vote was a recommendation, not an approval.
Will TB-500 or BPC-157 make me fail a drug test?
If you compete under WADA or USADA rules, yes. BPC-157 is prohibited under S0 and TB-500 under S2.3, both at all times — in and out of competition.
What actually helps a tendon heal?
Progressive graded loading has the strongest evidence, supported by adequate sleep and protein. A coach who can scale your training around the injury matters more than any supplement.
Come meet the BOOM family
Your first week is free — every class, either gym, no card. Come as you are and we’ll take care of the rest. We can’t wait to meet you!
Start my free week